Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M. Flynn, Nahida Chakhtoura, Katie McCarthy et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2017Cited by 219
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 63
Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention TrialSeema Shah, Mary Glenn Fowler, Alex John London et al.|Clinical Trials|2021Cited by 14
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the GlobePat Flynn, Lynda Stranix‐Chibanda, Sean S. Brummel et al.|AIDS and Behavior|2019Cited by 9
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and IndiaNeetal Nevrekar, Nishi Suryavanshi, Kevin Butler et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2022Cited by 6